Association of obstructive sleep apnea syndrome with the signs of non-alcoholic fatty liver disease and calculated glomerular filtration rate in metabolic syndrome

  • Authors: Severova MM1, Fomin VV1, Lebedeva MV1, Sorokin Y.D1, Saginova EA1, Minakova EG1, Gallyamov MG2, Mukhin NA1
  • Affiliations:
    1. E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases
    2. M. V. Lomonosov Moscow State University
  • Issue: Vol 82, No 6 (2010)
  • Pages: 35-39
  • Section: Articles
  • URL: https://ter-arkhiv.ru/0040-3660/article/view/30607
  • Cite item

Abstract


Aim: to assess a relationship between obstructive sleep apnea syndrome (OSAS) and the signs of non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome (MS).
Material and methods. Serum total cholesterol, triglycerides, high-density lipoprotein cholesterol concentrations, fasting blood glucose, ASAT, ALAT, γ-glutamyl transpeptidase (γ-GT), alkaline phosphatase (AP), total bilirubin, uricemia, and creatininemia were determined in 32 patients (mean age 47.6±9.7 years) with MS. The authors also measured fasting blood insulin levels with the further calculation of the homeostatic model assessment (HOMA) index, as well as plasma C-peptide concentration. Abdominal ultrasound study and OSAS diagnosis by the routine scheme were made in all the patients.
Results. OSAS was associated with the significant increase in the body mass index (40.5±9.4 and 31.9±4.6 kg/m2; p = 0.001), waist circumference (130.0±22.5 and 107.5±11.0 cm; p = 0.001), and C-peptide levels (1611.0±614.0 pmol/l; p = 0.019), and the serum activities of γ-GT (117.0±57.0 and 42.0±14.0 IU/ml; p = 0.05) and AP (80.0±53.0 and 74.0±48.0 UI/ml; p = 0.05). The patients with OSAS had also a significantly lower glomerular filtration rate (GFR) estimated using the modification of diet in renal disease (MDRD) formula (66.0±19.0 and 82.0±21.0 ml/min/1.73 m2; p < 0.05).
Conclusion. The presence of OSAS in patients with MS is associated with the increase in laboratory signs of NAFLD and the decrease in the GFR calculated by the MDRD formula.

About the authors

M M Severova

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

Email: mseverova@mail.ru
E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

V V Fomin

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

Email: fomin_vic@mail.ru
E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

M V Lebedeva

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

Email: marinaamica@mail.ru
E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

Yu D Sorokin

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

Email: sorokin-doc@mail.ru
E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

E A Saginova

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

Email: med02@yandex.ru
E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

E G Minakova

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

M G Gallyamov

M. V. Lomonosov Moscow State University

Email: mgtabib@gmail.com
факультет фундаментальной медициныаспирант, каф. внутренних болезней; МГУ им. М. В. Ломоносова; M. V. Lomonosov Moscow State University

N A Mukhin

E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

Email: moukhin-nephro@yandex.ru
E. M. Tareyev Clinic of Nephrology, Internal and Occupational Diseases

References

  1. Комитет экспертов ВНОК. Проект рекомендаций экспертов Всероссийского научного общества кардиологов по диагностике и лечению метаболического синдрома. М.; 2009.
  2. Чазова И. Е., Мычка В. Б. Метаболический синдром. М.; 2004.
  3. Лазебник Л. Б., Звенигородская Л. А., Егорова Е. Г. Метаболический синдром у пациентов с заболеваниями органов пищеварения. Тер. арх. 2007; 79 (10): 9-13.
  4. Sowers J. R. The cardiomethabolic syndrome and liver disease. J. Cardiometab. Syndr. 2008; 3: 7-11.
  5. Cuspidi C., Valerio C.,Giudici V. et al. Metabolic syndrome an multiple organ damage in essential hypertension. Blood Press. 2008; 17 (4): 195-203.
  6. Chang Y., Ryu S., Sung E. et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 2008; 57 (4): 569-576.
  7. Goland S., Shimoni S., Zornitzki T. et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment. J. Clin. Gastroenterol. 2006; 40 (10): 949-955.
  8. Чазова И. Е., Литвин А. Ю. Артериальная гипертония и синдром обструктивного апноэ во время сна. В кн.: Чазов Е. И., Чазова И. Е. Руководство по артериальной гипертонии. М.: Media Medica; 2005. 182-200.
  9. Tanné F., Gagnadoux F., Chazouilléres O. et al. Chronic liver injury during obstructive sleep apnea. Hepatology 2005; 41 (6): 1290-1296.
  10. Российское медицинское общество по артериальной гипертонии - Всероссийское научное общество кардиологов. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр). М.; 2008.
  11. Комитет экспертов ВНОК-НОНР. Основные положения проекта рекомендаций Всероссийского научного общества кардиологов и Научного общества нефрологов России по оценке функционального состояния почек у больных сердечно-сосудистыми заболеваниями или с повышенным риском их развития. Кардиоваск. тер. и профилакт. 2008; 4: 8-20.
  12. Огурцов П. П., Нужный В. П. Экспресс-диагностика (скрининг) хронической алкогольной интоксикации у больных соматического профиля. Клин. фармакол. и тер. 2001; 1: 34-39.
  13. Шарипова Г. Х., Саидова М. А., Балахонова Т. В. и др. Особенности поражения органов-мишеней у больных артериальной гипертонией с наличием и в отсутствие метаболического синдрома. Тер. арх. 2009; 6: 67-72.
  14. Bradley T. D., Floras J. S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009; 373: 82-93.
  15. Farrel G. S., Larters C. Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (2, suppl. 1): S99-S112.
  16. Hanley A. J., Williams K., Festa A. et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004; 53 (10): 2623-2632.
  17. Tominaga K., Fujimoto E., Suzuki K. et al. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ. Hlth Prev. Med. 2009; 14 (2): 142-149.
  18. Lemoine M., Ratziu V., Kim M. et al. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Liver Int. 2009; 29 (9): 1431-1438.
  19. Verhulst S. L., Jacobs S., Aerts L. et al. Sleep-disordered breathing: a new risk factor of suspected fatty liver disease in overweight children and adolescents? Sleep Breath 2009; 13 (2): 207-210.
  20. Polotsky V. Y., Patil S. P., Savransky V. et al. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Am. J. Respir. Crit. Care Med. 2009; 179 (3): 228-234.
  21. Mishra P., Nugent C., Afendy A. et al. Apnoeic-hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int. 2008; 28 (8): 1080-1086.
  22. Kallwitz E. R., Herdegen J., Madura J. et al. Liver enzymes and histology in obese patients with obstructive sleep apnea. J. Clin. Gastroenterol. 2007; 41 (10): 918-921.
  23. Savransky V., Bevans S., Nanayakkara A. et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am. J. Physiol. Gastrointest. Liver. Physiol. 2007; 293 (4): G871-G877.
  24. Okin P. M., Jern S., Devereux R. B. et al. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients: the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 2000; 35 (1, pt 1): 13-18.
  25. Ryu S., Chang Y., Kim D. I. et al. Gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin. Chem. 2007; 53 (1): 71- 77.
  26. Chang Y., Ryu S., Sung E. et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism 2008; 57 (4): 569-576.
  27. Lee D. S., Evans J. C., Robins S. J. et al. Gamma-glutamyltransferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler. Thromb. Vasc. Biol. 2007; 27 (1): 127-133.

Statistics

Views

Abstract - 25

Cited-By


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies